SCHEMBL25713331

SCHEMBL25713331

COc1ccc(COc2cccc3c2CC2(CCCCC2)C3=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.43
PTGER1 P34995 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.40
RECQL P46063 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
CRBN Q96SW2 1/20 0.39
IKZF3 Q9UKT9 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28440460 0.84 DRD2 (0.46) ABCB1PTGER1POLBRECQLDRD2
SCHEMBL11242408 0.81 ACHE (0.45) POLBHTR2AHTR2CHTR2BHTR1A
SCHEMBL30897244 0.81 TLR9 (0.43) PTGER1DRD2HTR2AHTR2CHTR2B
SCHEMBL22440588 0.81 TLR9 (0.43) PTGER1DRD2HTR2AHTR2CHTR2B
SCHEMBL15692718 0.80 ACHE (0.46) POLBHTR2AHTR2CHTR2BCRBN
SCHEMBL25713351 0.78 PTGER1 (0.35) ABCB1PTGER1NPC1RAB9APOLB
SCHEMBL15692861 0.77 ACHE (0.46) POLBHTR2AHTR2CHTR2BCRBN
SCHEMBL8779044 0.75 HTT (0.52) PTGER1POLBRECQLDRD2HTR2A
SCHEMBL15692838 0.74 ACHE (0.49) POLBHTR2AHTR2CHTR2BCRBN
SCHEMBL11242839 0.73 ALDH1A1 (0.43) ABCB1HTR2AHTR2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685748-B2 Spiro aromatic ring compound and application thereof ETERN BIOPHARMA (SHANGHAI) CO., LTD. (CN) 2023-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685748-B2 Spiro aromatic ring compound and application thereof PTPN1, PTPN11, PTPN5 ABCB1 1389/4885PTGER1 2542/4885NPC1 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.